VPM serves as a think-tank, and includes a world-leading faculty of scientists, clinical opinion leaders, industry experts and decision-makers. It is a unique opportunity for networking and exchanging knowledge, skills and experiences in the field of ischaemic heart disease.
A multitude of technical advances and clinical trials in the field were conceived at this meeting. The programme addresses the state-of-the-art developments in the fundamental mechanisms of atherosclerosis, technical advances in the diagnosis and risk stratification of the disease, as well as the most recent developments in clinical trials. There are always extensive discussions on future research directions.
The meeting faculty consists of nearly 80 internationally renowned researchers, as well as key industry partners that were invited to participate in discussions and contribute to advancing the field.
Please register for online access to the meeting.
The Imperial Vulnerable Plaque and Patient Meeting is now approved for 18 category 1 (external) CPD credits by the Royal College of Physicians!
Programme
View the full programme (PDF)
Session |
Speakers include |
|
Keynote Lecture |
Gerard Pasterkamp |
|
Mechanisms/ targets for novel therapeutics – Lipids and Inflammation |
Ziad Mallet, Jason Johnson, Jane Mitchell, Isabel Goncalves, Jason Johnson, Stephen White |
|
Mechanisms/ targets for novel therapeutics – Infections and Lifestyle |
Amir Lerman, Jan Nilsson, Licia Iacoviello Emilio Ros, Hendrick Sager |
|
Novel experimental models of atherosclerosis |
Michael Joner, Lilach Lerman, Paul Evans, Adam Hartley, Chiara Giannarelli |
|
AI, remote monitoring and biomarkers |
Ramzi Khamis, William Wijns, Amir Lerman, Ioanna Tzoulaki, Peter Sever |
|
Microvascular Pathology and Plaque Vulnerability |
Aloke Finn, Stephen Hoole, Tom Van De Hoef, John Ambrose |
|
Champagne Celebration – 20 Years of VPM |
Jim Muller, Amir Lerman, Wolfgang Koenig, Gregg Stone, Patrick Serruys |
|
Novel Methods for non-invasive imaging |
Mengxing Tang, Yoshi Obuonuma, Hans Reiber |
|
CT-based tissue characterisation and AI |
Damini Dey, Michiel Schaap, Jouke Dijkstra |
|
Keynote lectures – clinical burden of plaque vulnerability |
David Erlinge, Gabriel Steg, Wolfgang Koenig |
|
Novel anti-inflammatory therapies |
Jean-Claude Tardif, Paul Ridker |
|
Lipid-lowering therapies |
Lorenz Raber, Steve Nissen, Wolfgang Koenig |
|
Update on anti-thrombotic therapies |
Yoshi Obuonuma, Davide Capodanno, Gabriel Steg |
|
Debate: Physiology vs. image guided PCI intermediate lesions |
Gregg Stone, Bon-Kwon Koo |
|
Local therapies – pre-emptive treatment of vulnerable plaque |
Jim Muller, Ranil de Silva, Takashi Akasaka |
|
Treatment of coronary microvascular dysfunction |
Richard Good, Divaka Perera, Giovanni Luigi de Maria |
